메뉴 건너뛰기




Volumn 2, Issue 2, 2009, Pages 165-167

Preclinical safety validation of a stabilized viral vector direct injection approach to the cervical spinal cord

Author keywords

Adeno associatedviral vector; Cervical spinal cord; Gene therapy; Pig; Targeted delivery

Indexed keywords

GREEN FLUORESCENT PROTEIN; PARVOVIRUS VECTOR;

EID: 76949104119     PISSN: 17528054     EISSN: 17528062     Source Type: Journal    
DOI: 10.1111/j.1752-8062.2008.00084.x     Document Type: Article
Times cited : (21)

References (11)
  • 2
    • 0042528664 scopus 로고    scopus 로고
    • Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model
    • Kaspar BK, Llado J, Sherkat N, Rothstein JD, Gage FH. Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model. Science. 2003; 301 (5634): 839-842.
    • (2003) Science , vol.301 , Issue.5634 , pp. 839-842
    • Kaspar, B.K.1    Llado, J.2    Sherkat, N.3    Rothstein, J.D.4    Gage, F.H.5
  • 4
    • 0029101080 scopus 로고
    • Adenovirus-mediated gene therapy for experimental spinal cord tumors: Tumoricidal efficacy and functional outcome
    • Colak A, Goodman JC, Chen SH, Woo SL, Grossman RG, Shine HD. Adenovirus-mediated gene therapy for experimental spinal cord tumors: Tumoricidal efficacy and functional outcome. Brain Res. 1995; 691 (1-2): 76-82.
    • (1995) Brain Res. , vol.691 , Issue.1-2 , pp. 76-82
    • Colak, A.1    Goodman, J.C.2    Chen, S.H.3    Woo, S.L.4    Grossman, R.G.5    Shine, H.D.6


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.